Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Gross Profit Margin for the year ending March 31, 2024: 25.21%

Yuki Gosei Kogyo Co., Ltd. Gross Profit Margin is 25.21% for the year ending March 31, 2024, a 6.15% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Yuki Gosei Kogyo Co., Ltd. Gross Profit Margin for the year ending March 31, 2023 was 23.75%, a 24.60% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Gross Profit Margin for the year ending March 31, 2022 was 19.06%, a 16.02% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Gross Profit Margin for the year ending March 31, 2021 was 16.43%, a -23.45% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Gross Profit Margin for the year ending March 31, 2020 was 21.46%, a 23.64% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Health Care
Industries
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 1, 2025

Any question? Send us an email